Anticoagulation Laurel Newman Quality implementation Manager Primary Care Clinical Program
Objectives 1. Clinical program strategy for 2017 2. Correctly prescribe warfarin in iCentra 3. Utilization of the Monthly Patient Watch List 4. Anticoagulation webpage
Medical Group Leadership Responsible for operations to provide safe and effective management of patients who require anticoagulation. The Ask: Support Anticoagulation best practice philosophy and operations • Assure physicians and staff participate in iCentra “Go Live” training • Allow for clinical staff to enroll patients into the protocol prior to “Go Live” • Define a workflow for each clinic (POC vs lab) • Identify a physician leader and clinical staff leader in each clinic and have • them attend clinical program quarterly meetings
Our Proposal Maintenance (On iCentra and using the protocol) • Laurel will hold quarterly meetings with: • The appointed PPC anticoagulation lead • Staff anticoagulation lead • John Bracken’s team • Clinical Quality Region Lead • iCentra ambulatory workflow leads • John Bracken’s team will train new employees
Models Each Provider manages their own patients • Point of Care in the clinic (preferred method) • Utilization of lab services Region Anticoagulation Clinic managed by APC or pharmacy services
Prescribing Warfarin in iCentra Pre-populated Warfarin Orders can be added to your favorites.
Prescribing Warfarin in iCentra Weekly doses will be managed in the Anticoagulation workflow, not the medication list.
Review your list to determine: Is this patient still taking warfarin? If not, remove the patient • from the protocol. If they are taking warfarin, does the indication warrant • indefinite therapy or perhaps are they a candidate for cessation (e.g. surgically provoked DVT/PE). If they require continued anticoagulation therapy and are • having a difficult time achieving a safe time in therapeutic range (TTR), can modifiable barriers to optimal anticoagulation be identified? Seeing patients with poor INR control more frequently is • associated with improving TTR. Among patients on warfarin with suboptimal anticoagulation • control, might transition to a DOAC be a consideration? A dedicated visit to address anticoagulation therapy can • improve quality of anticoagulation management.
Updated Anticoagulation Web Page
Approaches to Educating Patients on Oral Anticoagulation Amy A. Levesque
Managing >8 INRs in an Anticoagulation clinic. Sean OBrien
Managing >8 INRs in an Anticoagulation clinic. Sean OBrien
Pharmacist Objectives Compare and contrast differences between adult and
The pitfalls of Any Qualified Provider (AQP) Joanne Malpass, Anticoagulation
Inpatient Anticoagulation Management Services to Improve Transitions of Care
Latest Frontiers in Anticoagulation Therapy Your key questions for 2018
Latest Frontiers in Anticoagulation Therapy Your key questions for 2018
An Inpatient Perspective on the Joint Commission National Patient Safety
ADAS Referral Site Anticoagulation Dosing Advisory Service Blackpool Hospital
Winship Cancer Institute of Emory University New Anticoagulants: When and Why
Improving Stroke Prevention in Patients With Atrial Fibrillation
Application for approval to manufacture ESN containing sodium nitrite and a
Dose Response Assessments: Guidance, Experience, Expectations Vikram Sinha,
How Technology Assessment by Hospitals Differs from Technology Assessment by
A mathematical model of surface-mediated enzyme inhibition under flow
Updates in Thrombosis Dr. Ali Y. Al-Muhaini MBBch FRCP(C) Chairman of the
Showcasing health innovation Dr Samus ONeill Chair AHSN Network, CEO AHSN
Drug Spending % of Healthcare Spending DRUG SPENDING % OF HEALTHCARE SPENDING
EXPANDED MANDATE: MEDICINES PATENT POOL FOR ESSENTIAL MEDICINES KEY FINDINGS
Atrial fibrillation Reducing The Risk of Stroke Bjrn Fredriksson Arrhythmia
Sandy Bartlett, PhD, PharmD, BCPS Associate Professor | Department of Pharmacy